[IKT] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 20.47%
YoY- -2.22%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 80 116 65 123 -
PBT -4,960 -4,650 -4,178 -4,595 -5,778 -4,478 -4,279 10.35%
Tax 0 0 0 46 37 -474 -112 -
NP -4,960 -4,650 -4,178 -4,595 -5,778 -4,003 -4,167 12.32%
Tax Rate - - - - - - - -
Total Cost 4,960 4,650 4,178 4,675 5,894 4,068 4,291 10.15%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -417,794,000.00 -5,775.11 -4,963.46 -6,204.86 -3,375.91 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.66 -0.73 -0.68 -0.86 -1.11 -0.87 -0.99 -23.70%
EPS Diluted -0.66 -0.73 -0.68 -0.86 -1.11 -0.87 -0.99 -23.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.